Previous Issue
Volume 7, March
 
 

Organics, Volume 7, Issue 2 (June 2026) – 1 article

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
35 pages, 10285 KB  
Article
Synthesis, Characterization, and Multidimensional In Silico Evaluation of Novel Etodolac-Based 1,3,4-Oxadiazole Derivatives as Potential Anticancer Agents
by Tiba M. Hameed, Rafid M. Hashim, S. J. Abed, Raneen Hashim Ridha and O. Al-Mohammed Baqer
Organics 2026, 7(2), 15; https://doi.org/10.3390/org7020015 - 7 Apr 2026
Abstract
A new series of eight novel etodolac-based 1,3,4-oxadiazoles was synthesized, characterized, and tested in silico in multidimensional routes, starting with etodolac, a well-known nonsteroidal anti-inflammatory medication (NSAID). In silico studies were performed prior to synthesis using the molecular docking technique in CCDC GOLD [...] Read more.
A new series of eight novel etodolac-based 1,3,4-oxadiazoles was synthesized, characterized, and tested in silico in multidimensional routes, starting with etodolac, a well-known nonsteroidal anti-inflammatory medication (NSAID). In silico studies were performed prior to synthesis using the molecular docking technique in CCDC GOLD suite software (2025.3) to assess the interactions with two key targets involved in cancer pathogenesis: the crystal structure of the epidermal growth factor receptor EGFR tyrosine kinase domain (PDB ID: 4HJO) and the matrix metalloproteinase (MMP-9) complex (PDB ID: 5CUH). ADME studies were performed to assess the physicochemical properties of the synthesized molecules. Importantly, biotransformation prediction also indicated that the derivatives possess high metabolic stability, with hydroxylation of the thio-ether group as the primary predicted biotransformation route. All compounds were characterized using melting point, FT-IR, 1H-NMR, and 13C-NMR spectroscopy. In vitro and/or in vivo experiments are needed to confirm this preliminary anticancer study. Full article
(This article belongs to the Collection Advanced Research Papers in Organics)
Show Figures

Figure 1

Previous Issue
Back to TopTop